Collateral Scores in Acute Ischemic Stroke : A retrospective study assessing the suitability of collateral scores as standalone predictors of clinical outcome.


Journal

Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 18 07 2019
accepted: 07 11 2019
pubmed: 30 11 2019
medline: 6 11 2021
entrez: 30 11 2019
Statut: ppublish

Résumé

Several collateral scores have been published for stroke in the middle cerebral artery territory, each considering different aspects of cerebral collateralization. Currently, there is no gold standard in CT-based collateral assessment. The aim of this retrospective study was to compare five collateral scores and determine whether they are able to predict clinical outcome after thrombectomy as standalone parameters. Inclusion criteria were M1 occlusion, premorbid modified Rankin scale (mRS) of 0-3, treatment with endovascular thrombectomy and groin puncture within 12 h after stroke onset. The Maas et al., Miteff et al., Tan et al., ASITN/SIR and mCTA collateral scores were retrospectively assessed in multiphase CTA images and correlated with 90-day mRS (90d-mRS) scores. Good outcome was defined as 90d-mRS 0-2 or unchanged to premorbid mRS. In total, 108 patients were included of which 39.8% achieved a good outcome. The area under the curve (AUC) values of receiver operating characteristic (ROC) curve analysis for Maas et al., Miteff et al., Tan et al., ASITN/SIR and mCTA scores were 0.60 (0.51-0.70), 0.60 (0.52-0.68), 0.61 (0.51-0.70), 0.59 (0.49-0.70) and 0.61 (0.50-0.71), respectively. The correlation between 90d-mRS and Maas (r = -0.16, P = 0.091), Miteff (r = -0.25, P = 0.009), Tan (r = -0.26, P = 0.007), ASITN/SIR (r = -0.21, P = 0.030) and mCTA (r = -0.22, P = 0.021) scores was poor. Although collaterals are known to correlate with clinical outcome, none of the analyzed collateral scores sufficiently predicted outcome as a standalone parameter.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Several collateral scores have been published for stroke in the middle cerebral artery territory, each considering different aspects of cerebral collateralization. Currently, there is no gold standard in CT-based collateral assessment. The aim of this retrospective study was to compare five collateral scores and determine whether they are able to predict clinical outcome after thrombectomy as standalone parameters.
METHODS METHODS
Inclusion criteria were M1 occlusion, premorbid modified Rankin scale (mRS) of 0-3, treatment with endovascular thrombectomy and groin puncture within 12 h after stroke onset. The Maas et al., Miteff et al., Tan et al., ASITN/SIR and mCTA collateral scores were retrospectively assessed in multiphase CTA images and correlated with 90-day mRS (90d-mRS) scores. Good outcome was defined as 90d-mRS 0-2 or unchanged to premorbid mRS.
RESULTS RESULTS
In total, 108 patients were included of which 39.8% achieved a good outcome. The area under the curve (AUC) values of receiver operating characteristic (ROC) curve analysis for Maas et al., Miteff et al., Tan et al., ASITN/SIR and mCTA scores were 0.60 (0.51-0.70), 0.60 (0.52-0.68), 0.61 (0.51-0.70), 0.59 (0.49-0.70) and 0.61 (0.50-0.71), respectively. The correlation between 90d-mRS and Maas (r = -0.16, P = 0.091), Miteff (r = -0.25, P = 0.009), Tan (r = -0.26, P = 0.007), ASITN/SIR (r = -0.21, P = 0.030) and mCTA (r = -0.22, P = 0.021) scores was poor.
CONCLUSION CONCLUSIONS
Although collaterals are known to correlate with clinical outcome, none of the analyzed collateral scores sufficiently predicted outcome as a standalone parameter.

Identifiants

pubmed: 31781803
doi: 10.1007/s00062-019-00858-1
pii: 10.1007/s00062-019-00858-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

789-793

Références

Bang OY, Saver JL, Buck BH, Alger JR, Starkman S, Ovbiagele B, et al. Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 2008;79:625–9.
doi: 10.1136/jnnp.2007.132100
Pham M, Bendszus M. Facing time in ischemic stroke: an alternative hypothesis for collateral failure. Clin Neuroradiol. 2016;26:1–11.
doi: 10.1007/s00062-016-0507-2
Goyal M, Menon BK, Derdeyn CP. Perfusion imaging in acute ischemic stroke: let us improve the science before changing clinical practice. Radiology. 2013;266:16–21.
doi: 10.1148/radiol.12112134
McVerry F, Liebeskind DS, Muir KW. Systematic review of methods for assessing Leptomeningeal collateral flow. AJNR Am J Neuroradiol. 2012;33:576–82.
doi: 10.3174/ajnr.A2794
Seker F, Potreck A, Möhlenbruch M, Bendszus M, Pham M. Comparison of four different collateral scores in acute ischemic stroke by CT angiography. J Neurointerv Surg. 2016;8:1116–8.
doi: 10.1136/neurintsurg-2015-012101
Potreck A, Seker F, Hoffmann A, Pfaff J, Nagel S, Bendszus M, et al. A novel method to assess pial collateralization from stroke perfusion MRI: subdividing T
doi: 10.1007/s00330-016-4415-2
Frölich AM, Schrader D, Klotz E, Schramm R, Wasser K, Knauth M, et al. 4D CT angiography more closely defines Intracranial thrombus burden than single-phase CT angiography. AJNR Am J Neuroradiol. 2013;34:1908–13.
doi: 10.3174/ajnr.A3533
Maas MB, Lev MH, Ay H, Singhal AB, Greer DM, Smith WS, et al. Collateral vessels on CT angiography predict outcome in acute ischemic stroke. Stroke. 2009;40:3001–5.
doi: 10.1161/STROKEAHA.109.552513
Miteff F, Levi CR, Bateman GA, Spratt N, McElduff P, Parsons MW. The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain. 2009;132:2231–8.
doi: 10.1093/brain/awp155
Tan IY, Demchuk AM, Hopyan J, Zhang L, Gladstone D, Wong K, et al. CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol. 2009;30:525–31.
doi: 10.3174/ajnr.A1408
Higashida RT, Furlan AJ. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34:e109–37.
doi: 10.1161/01.STR.0000082721.62796.09
Menon BK, d’Esterre CD, Qazi EM, Almekhlafi M, Hahn L, Demchuk AM, et al. Multiphase CT angiography: a new tool for the imaging triage of patients with acute ischemic stroke. Radiology. 2015;275:510–20.
doi: 10.1148/radiol.15142256
Seker F, Potreck A, Möhlenbruch M, Bendszus M, Pham M. Comparison of four different collateral scores in acute ischemic stroke by CT angiography. J Neurointerv Surg. 2016;8:1116–8.
doi: 10.1136/neurintsurg-2015-012101
Elijovich L, Goyal N, Mainali S, Hoit D, Arthur AS, Whitehead M, et al. CTA collateral score predicts infarct volume and clinical outcome after endovascular therapy for acute ischemic stroke: a retrospective chart review. J Neurointerv Surg. 2016;8:559–62.
doi: 10.1136/neurintsurg-2015-011731
Ginsberg MD. The cerebral collateral circulation: relevance to pathophysiology and treatment of stroke. Neuropharmacology. 2018;134:280–92.
doi: 10.1016/j.neuropharm.2017.08.003
Bang OY, Goyal M, Liebeskind DS. Collateral circulation in ischemic stroke. Stroke. 2015;46:3302–9.
doi: 10.1161/STROKEAHA.115.010508
Leng X, Fang H, Leung TW, Mao C, Xu Y, Miao Z, et al. Impact of collateral status on successful revascularization in endovascular treatment: a systematic review and meta-analysis. Cerebrovasc Dis. 2016;41:27–34.
doi: 10.1159/000441803
Román LS, Menon BK, Blasco J, Hernández-Pérez M, Dávalos A, Majoie CBLM, et al. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data. Lancet Neurol. 2018;17:895–904.
doi: 10.1016/S1474-4422(18)30242-4
Arenillas JF, Cortijo E, García-Bermejo P, Levy EI, Jahan R, Liebeskind D, et al. Relative cerebral blood volume is associated with collateral status and infarct growth in stroke patients in SWIFT PRIME. J Cereb Blood Flow Metab. 2018;38:1839–47.
doi: 10.1177/0271678X17740293
Seker F, Pfaff J, Potreck A, Mundiyanapurath S, Ringleb PA, Bendszus M, et al. Correlation of T
doi: 10.1002/brb3.772

Auteurs

Fatih Seker (F)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Benjamin Pereira-Zimmermann (B)

Department of Radiology, University of Valparaiso, Valparaiso, Chile.

Johannes Pfaff (J)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Jan Purrucker (J)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Christoph Gumbinger (C)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Silvia Schönenberger (S)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Martin Bendszus (M)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Markus A Möhlenbruch (MA)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. markus.moehlenbruch@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH